The Current Ratio as of December 2025 (TTM) for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) is 6.07

According to Jagsonpal Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 6.07. This represents a change of 97.44% compared to the average of 3.07 of the last 4 quarters.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) Historical Current Ratio (quarterly & annually)

How has JAGSNPHARM.BO Current Ratio performed in the past?

The mean historical Current Ratio of Jagsonpal Pharmaceuticals Limited over the last ten years is 4.48. The current 6.07 Current Ratio has changed 13.44% with respect to the historical average. Over the past ten years (40 quarters), JAGSNPHARM.BO's Current Ratio was at its highest in in the March 2024 quarter at 10.42. The Current Ratio was at its lowest in in the December 2015 quarter at 0.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Jagsonpal Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) Average Current Ratio

How has JAGSNPHARM.BO Current Ratio performed in the past?

The current Current Ratio of Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) Current Ratio vs. Peers

How is JAGSNPHARM.BO’s Current Ratio compared to its peers?

Jagsonpal Pharmaceuticals Limited’s Current Ratio is greater than Syncom Formulations (India) Limited (0), greater than Bajaj HealthCare Limited (1.75), greater than Bajaj HealthCare Limited (1.75), greater than Syncom Formulations (India) Limited (0), greater than Bliss GVS Pharma Limited (4.46), greater than Bliss GVS Pharma Limited (4.46), greater than Hester Biosciences Limited (1.44), greater than Hester Biosciences Limited (1.44), less than Megasoft Limited (8.39), greater than Sigachi Industries Limited (1.64),

Build a custom stock screener for Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jagsonpal Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jagsonpal Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.